Drug-eluting coronary stents

被引：37

作者：

Salam, AM ^{[1
]}

Al Suwaidi, J ^{[1
]}

Holmes, DR ^{[1
]}

机构：

[1] Hamad Gen Hosp, Cardiac Catheterizat Lab, Doha, Qatar

来源：

CURRENT PROBLEMS IN CARDIOLOGY | 2006年 / 31卷 / 01期

关键词：

D O I：

10.1016/j.cpcardiol.2005.09.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The introduction and widespread use of coronary stents have been the most important advancement in the percutaneous treatment of coronary artery disease since the introduction of balloon angioplasty. Coronary artery stents reduce the rate of angiographic and clinical restenosis compared to balloon angioplasty. This angiographic restenosis was further reduced with the introduction of drug-eluting stents and hence further reduction in the frequency of major adverse cardiac events. Herein we present a comprehensive and up-to-date review about the use of drug-eluting stents in the treatment of coronary artery disease.

引用

收藏

页码：8 / 119

页数：112

相关论文

共 369 条

[31] What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention? A meta-analysis [J].

Bavry, AA ;

Kumbhani, DJ ;

Helton, TJ ;

Bhatt, DL .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (06) :941-946

[32] In-stent stenosis: pathology and implications for the development of drug eluting stents [J].

Bennett, MR .

HEART, 2003, 89 (02) :218-224

[33] Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries - Results from the multicenter American research trial with cilazapril after angioplasty to prevent transluminal coronary obstruction and restenosis (MARCATOR) [J].

Berger, PB ;

Holmes, DR ;

Ohman, EM ;

OHanesian, MA ;

Murphy, JG ;

Schwartz, RS ;

Serruys, PW ;

Faxon, DP .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (01) :1-7

[34]

BERK BC, 1991, J AM COLL CARDIOL, V17, pB111

[35] Procedural results and intermediate clinical outcomes after multiple saphenous vein graft stenting [J].

Bhargava, B ;

Kornowski, R ;

Mehran, R ;

Kent, KM ;

Hong, MK ;

Lansky, AJ ;

Waksman, R ;

Pichard, AD ;

Satler, LF ;

Leon, MB .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) :389-397

[36] CLINICAL, PHYSIOLOGICAL, ANATOMIC AND PROCEDURAL FACTORS PREDICTIVE OF RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY [J].

BOURASSA, MG ;

LESPERANCE, J ;

EASTWOOD, C ;

SCHWARTZ, L ;

COTE, G ;

KAZIM, F ;

HUDON, G .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 18 (02) :368-376

[37] Cell cycle progression - New therapeutic target for vascular proliferative disease [J].

Braun-Dullaeus, RC ;

Mann, MJ ;

Dzau, VJ .

CIRCULATION, 1998, 98 (01) :82-89

[38] Comparison of stenting and balloon angioplasty for narrowings in aortocoronary saphenous vein conduits in place for more than five years [J].

Brener, SJ ;

Ellis, SG ;

AppersonHansen, C ;

Leon, MB ;

Topol, EJ .

AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (01) :13-18

[39] Insulin resistance and coronary artery disease [J].

Bressler, P ;

Bailey, SR ;

Matsuda, M ;

DeFronzo, RA .

DIABETOLOGIA, 1996, 39 (11) :1345-1350

[40]

Buellesfeld L, 2004, HERZ, V29, P167, DOI 10.1007/s00059-004-2557-5

← 1 2 3 4 5 6 7 8 9 10 →